Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Recent epidemiological and laboratory-based studies suggest that the anti-diabetic drug metformin prevents cancer progression. How metformin diminishes tumor growth is not fully understood. In this study, we report that in human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrog...
Main Authors: | William W Wheaton, Samuel E Weinberg, Robert B Hamanaka, Saul Soberanes, Lucas B Sullivan, Elena Anso, Andrea Glasauer, Eric Dufour, Gokhan M Mutlu, GR Scott Budigner, Navdeep S Chandel |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2014-05-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/02242 |
Similar Items
-
The effect of metformin on viability and mitochondrial status of tumor and non-tumor cell line
by: Ljubičić Jelena, et al.
Published: (2022-01-01) -
Metformin rescues rapamycin-induced mitochondrial dysfunction and attenuates rheumatoid arthritis with metabolic syndrome
by: Eun Kyung Kim, et al.
Published: (2020-04-01) -
Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients
by: Aranzazu M. de Marañón, et al.
Published: (2022-07-01) -
Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences
by: Eric Fontaine
Published: (2018-12-01) -
Therapeutic vs. Suprapharmacological Metformin Concentrations: Different Effects on Energy Metabolism and Mitochondrial Function in Skeletal Muscle Cells in vitro
by: Kasja Pavlovic, et al.
Published: (2022-07-01)